Restoration of F508-del function by transcomplementation: The partners meet in the endoplasmic reticulum

Emily Anne, Smith Bergbower, Inna Sabirzhanova, Clément Boinot, William B. Guggino, Liudmila Cebotaru

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background/Aims: Because of the small size of adeno-associated virus, AAV, the cystic fibrosis conductance regulator, CFTR, cDNA is too large to fit within AAV and must be truncated. We report here on two truncated versions of CFTR, which, when inserted into AAV1 and used to infect airway cells, rescue F508-del CFTR via transcomplementation. The purpose of this study is to shed light on where in the cell transcomplementation occurs and how it results in close association between the endogenous F508-del and truncated CFTR. Methods: We treated CF airway cells (CFBE41o-) with AAV2/1 (AAV2 inverted terminal repeats/AAV1 capsid) containing truncated forms of CFTR, ∆264 and ∆27-264 CFTR, who can restore the function of F508-del by transcomplementation. We addressed the aims of the study using a combination of confocal microscopy and short circuit currents measurements. For the latter, CF bronchial epithelial cells (CFBE) were grown on permeable supports. Results: We show that both F508-del and the truncation mutants colocalize in the ER and that both the rescued F508-del and the transcomplementing mutants reach the plasma membrane together. There was significant fluorescence resonance energy transfer (FRET) between F508-del and the transcomplementing mutants within the endoplasmic reticulum (ER), suggesting that transcomplementation occurs through a bimolecular interaction. We found that transcomplementation could increase the Isc in CFBE41o- cells stably expressing additional wt-CFTR or F508-del and in parental CFBE41o- cells expressing endogenous levels of F508-del. Conclusion: We conclude that the functional rescue of F508-del by transcomplementation occurs via a bimolecular interaction that most likely begins in the ER and continues at the plasma membrane. These results come at an opportune time for developing a gene therapy for CF and offer new treatment options for a wide range of CF patients.

Original languageEnglish (US)
Pages (from-to)1267-1279
Number of pages13
JournalCellular Physiology and Biochemistry
Volume52
Issue number6
DOIs
StatePublished - 2019

Keywords

  • Bimolecular interaction
  • Cystic fibrosis
  • Gene therapy
  • Transcomplementation
  • Truncated CFTR

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Restoration of F508-del function by transcomplementation: The partners meet in the endoplasmic reticulum'. Together they form a unique fingerprint.

Cite this